NOTICE: Last date for pre Christmas delivery - 22/12/25 - must choose Next Day Delivery. Medisave is closed 25/12/25, 26/12/25 and 01/01/26. We cannot guarantee delivery times for orders placed between 24/12/25 and 02/01/26
  • Decapeptyl SR 11.25mg powder and solvent for suspension for injection vials x 1 -
1 1

Smartway Pharma

Decapeptyl SR 11.25mg powder and solvent for suspension for injection vials x 1

Decapeptyl SR 11.25mg powder and solvent for suspension for injection vials x 1

£300.00 inc.VAT
£250.00 ex.VAT
£0.00 £300.00 inc.VAT
£250.00 ex.VAT
Sale Sold out

AVAILABLE TO BACKORDER - Buy now for despatch when stock arrives.

RESTRICTED PRODUCT: Professional purchase only. We will only supply registered customers providing valid GMC # or equivalent qualification. Credentials will be manually verified before any purchases are authorised. Delivery restricted to business address only. NOT FOR HOME/PRIVATE USE. Click here to apply.

When placing an order for pharmaceuticals please be advised the minimum order value must reach £25 ex VAT

SKU: DECAPEPTYL-11.25MG

More like this

Shipping

FREE STANDARD SHIPPING available on all orders over £25 EX VAT.

Next working day - available until 8pm Monday to Friday
Weekend despatch - available until 12pm Sunday for MONDAY delivery (Next working day)
Sat and Sunday delivery service - available until 5pm Friday.

Why buy from Medisave?

Medisave supplies health professionals, business and home users.

  • Credit card, PayPal and Amazon Payments accepted
  • Free delivery over £25 ex VAT
  • NHS, school or company purchase order - email accounts@medisave.co.uk
  • Laser engraving
  • Delivery to private or commercial addresses
  • Google Certified Shop
  • Registered with the Medicines and Healthcare products Regulatory Agency (MHRA)
  • ISO9001 quality management system + ISO 140001 environmental
  • Established 1999

Need some advice? Speak to our friendly team on 0800 804 6447

View full details

Decapeptyl SR is a type of hormone therapy used to treat certain types of prostate cancer. 

This includes:

  • High-risk localised prostate cancer (only in combination with radiotherapy).
  • Locally advanced, non-metastatic prostate cancer
  • Metastatic prostate cancer